ÖйúÖÕÄ©ÆÚÉö²¡»¼ÕßÈÏÖªÕϰӰÏìÒòËØµÄMeta·ÖÎö
ΣÏÕ,ÎÄÏ×,1×ÊÁÏÓë·½·¨,2½á¹û,3ÌÖÂÛ
ÕŻۣ¬ÑîÞ±£¬Îºµ¤£¬ÖÜ×Ͼ꣬×Þº£Å·*±¾Ñо¿¼ÛÖµ£º
(1)±¾Ñо¿·¢ÏÖÄêÁä¸ß¡¢Í¸ÎöÁ䳤¡¢¸ßѪѹ¡¢ÄÔ×äÖС¢ÌÇÄò²¡¡¢ºÏ²¢Ö¢Ö¸Êý¸ß¡¢ÒÖÓô¡¢¸ß¼××´ÅÔÏÙ¼¤ËØ(PTH)¡¢¸ßC·´Ó¦µ°°×(CRP)¡¢¸ßͬÐͰëë×°±Ëá(Hcy)ÊÇÖÕÄ©ÆÚÉö²¡(ESRD)»¼ÕßÈÏÖªÕϰ(CI)µÄΣÏÕÒòËØ£¬ÄÐÐÔ¡¢½ÌÓý³Ì¶È¸ß¡¢Ñªºìµ°°×(Hb)¸ß¡¢ÑªÇå°×µ°°×(ALB)¸ß¡¢ÑªÇ弡ôû(Cr)¸ßÊÇESRD»¼ÕßCIµÄ±£»¤ÒòËØ¡£ÔÚÁÙ´²¹¤×÷ÖУ¬Ò½ÎñÈËÔ±¿É²Î¿¼±¾Ñо¿µÄ½áÂÛ¶ÔCI·¢Éú·çÏոߵÄESRD»¼Õß½øÐÐÔ¤·À£¬»òΪÆäÖÆ¶©Õë¶ÔÐԵĸÉÔ¤´ëÊ©¡£(2)±¾Ñо¿·¢ÏÖ£¬ÈÔÓÐһЩÒòËØÈçÐÄѪ¹Ü²¡Ê·¡¢Æ¶ÑªµÈÓëESRD»¼Õß·¢ÉúCIµÄ¹ØÏµ²»Ã÷È·£¬ÇÒÓйØÍ¸ÎöÓ°ÏìÒòËØµÄÑо¿¹ýÉÙ£¬Òò´Ë£¬½ñºó»¹Ð迪չ¶àÖÐÐÄ¡¢´óÑù±¾µÄÑо¿½øÒ»²½Ã÷È· ESRD»¼ÕßCIµÄÓ°ÏìÒòËØ£¬ÓÈÆäÊÇ͸Îö¡¢ÉöÔಡÏà¹ØÒòËØ¡£
ÂýÐÔÉöÔ༲²¡(chronic kidney disease£¬CKD)ÊÇĿǰȫÇò·¶Î§ÄڵĹ«¹²ÎÀÉúÎÊÌ⣬2013ÄêÈ«ÇòCKD»¼²¡ÂÊΪ8%¡«16%[1]¡£ÎÒ¹úÊÇCKD´ó¹ú£¬2018ÄêµÄÒ»ÏîMeta·ÖÎöÏÔʾ£¬ÎÒ¹úCKDδ±ê»¯»¼²¡ÂÊΪ12.49%[2]¡£ÖÕÄ©ÆÚÉö²¡(endstage renal disease£¬ESRD)ÊÇÓɶàÖÖÔ·¢ÐÔ»ò¼Ì·¢ÐÔÒòËØµ¼ÖµÄCKD½øÕ¹µ½×îºó½×¶Î[3]£¬¸¹Ä¤Í¸Îö(peritoneal dialysis£¬PD)ºÍѪҺ͸Îö(hemodialysis£¬HD)ÊÇĿǰÖ÷ÒªµÄÖÎÁÆ·½°¸[4]¡£È«ÇòÐèÒªÉöÔàÌæ´úÁÆ·¨µÄESRD»¼ÕßÓÐ490Íò¡«708ÍòÈË[5]¡£Ñо¿ÏÔʾ£¬ÖÁ2017ÄêÖйú½ÓÊÜ͸ÎöÖÎÁƵÄESRD»¼Õß³¬¹ý52ÍòÈË£¬ESRDÒѳÉΪÎÒ¹úÑÏÖØÎ£º¦½¡¿µ¡¢¼ÓÖØ¾¼Ã¸ºµ£µÄ¹«¹²ÎÀÉúÎÊÌâ[6]¡£
³ýÍâÉöÔ๦ÄܵÄÌØÕ÷±íÏÖ£¬Ñо¿Õß»¹·¢ÏÖÈÏÖªÕϰ(cognitive impairment£¬CI)ÔÚESRD»¼ÕßÖеķ¢²¡Âʽϸߡ£Ä¿Ç°¹úÄÚ±¨µÀµÄPD»¼ÕßCI·¢²¡ÂÊΪ16.8%¡«58.6%[7-9]£¬HD»¼ÕßCIµÄ·¢²¡ÂÊΪ51.6%¡«80.9%[10-11]¡£ÈÏÖª¹¦ÄܶÔÓÚESRD»¼ÕßÓÈÎªÖØÒª£¬ÓÈÆäÊǽÓÊÜά³ÖÐÔ͸ÎöµÄ»¼Õߣ¬ÐèÒª³¤ÆÚ½øÐÐÒûʳ¿ØÖÆ£¬¼á³Ö·þÒ©ºÍ¹æÂÉËæ·Ã£¬¾ùÒÀ¿¿½Ï¸ßµÄÈÏÖª¹¦ÄÜ¡£Í¬Ê±£¬CI»áËæ×Åʱ¼ä½øÕ¹Öð½¥¶ñ»¯£¬ºÏ²¢Çá¶ÈÈÏÖªÕϰ(mild cognitive impairment£¬MCI)µÄ»¼ÕßÓÐ15%µÄ¿ÉÄÜ»á½øÕ¹Îª°¢¶û´Äº£Ä¬²¡(Alzheimer's disease£¬AD)£¬83.8%µÄAD»¼ÕßÈ·Õïǰ2ÄêÔø±»Õï¶ÏΪMCI£¬ËµÃ÷MCI¾ßÓнϸߵÄADת»¯ÂÊ[12]£¬»á½øÒ»²½¼ÓÖØÉç»á¸ºµ£¡£µ«CIÒ²¾ßÓÐÒ»¶¨µÄ¿ÉÄæÐÔ[13]£¬ÔçÆÚÔ¤·À¡¢ÔçÆÚ¸ÉÔ¤¿ÉÒÔÑÓ»ºCIµÄ½øÒ»²½·¢Õ¹ ......
ÄúÏÖÔڲ鿴ÊÇÕªÒªÒ³£¬È«Îij¤ 12121 ×Ö·û¡£